title: Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
authors.forename: M
authors.initials: M
authors.lastname: Kuloglu
authors.forename: O
authors.initials: O
authors.lastname: Ekinci
authors.forename: A
authors.initials: A
authors.lastname: Caykoylu
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D002065:Buspirone / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D011569:Psychiatric Status Rating Scales; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D012720:Severity of Illness Index; D020186:Sleep Bruxism / Q000139:chemically induced*; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D002065:Buspirone; D003511:Cyclohexanols; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride